|
Name |
trans-Calamenene
|
Molecular Formula | C15H22 | |
IUPAC Name* |
(1S,4R)-1,6-dimethyl-4-propan-2-yl-1,2,3,4-tetrahydronaphthalene
|
|
SMILES |
C[C@H]1CC[C@@H](C2=C1C=CC(=C2)C)C(C)C
|
|
InChI |
InChI=1S/C15H22/c1-10(2)13-8-6-12(4)14-7-5-11(3)9-15(13)14/h5,7,9-10,12-13H,6,8H2,1-4H3/t12-,13+/m0/s1
|
|
InChIKey |
PGTJIOWQJWHTJJ-QWHCGFSZSA-N
|
|
Synonyms |
trans-Calamenene; (+)-trans-Calamenene; XCK5IBT7TK; Calamenene, trans-(+)-; (-)-Calamenene; Naphthalene, 1,2,3,4-tetrahydro-1,6-dimethyl-4-(1-methylethyl)-, (1S,4R)-; 40772-39-2; UNII-XCK5IBT7TK; (1R,4S)-4-Isopropyl-1,6-dimethyl-1,2,3,4-tetrahydronaphthalene; ZINC59587184; Q67880179
|
|
CAS | 40772-39-2 | |
PubChem CID | 6429022 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 202.33 | ALogp: | 5.1 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.595 |
Caco-2 Permeability: | -4.52 | MDCK Permeability: | 0.00001490 |
Pgp-inhibitor: | 0.707 | Pgp-substrate: | 0.007 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.966 |
30% Bioavailability (F30%): | 0.994 |
Blood-Brain-Barrier Penetration (BBB): | 0.4 | Plasma Protein Binding (PPB): | 97.31% |
Volume Distribution (VD): | 3.02 | Fu: | 2.81% |
CYP1A2-inhibitor: | 0.57 | CYP1A2-substrate: | 0.937 |
CYP2C19-inhibitor: | 0.727 | CYP2C19-substrate: | 0.949 |
CYP2C9-inhibitor: | 0.58 | CYP2C9-substrate: | 0.818 |
CYP2D6-inhibitor: | 0.103 | CYP2D6-substrate: | 0.729 |
CYP3A4-inhibitor: | 0.606 | CYP3A4-substrate: | 0.765 |
Clearance (CL): | 6.61 | Half-life (T1/2): | 0.153 |
hERG Blockers: | 0.033 | Human Hepatotoxicity (H-HT): | 0.219 |
Drug-inuced Liver Injury (DILI): | 0.407 | AMES Toxicity: | 0.142 |
Rat Oral Acute Toxicity: | 0.143 | Maximum Recommended Daily Dose: | 0.898 |
Skin Sensitization: | 0.162 | Carcinogencity: | 0.241 |
Eye Corrosion: | 0.857 | Eye Irritation: | 0.981 |
Respiratory Toxicity: | 0.212 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001822 | 1.000 | D06GIP | 0.373 | ||||
ENC002065 | 0.556 | D01JMC | 0.258 | ||||
ENC001823 | 0.547 | D04CSZ | 0.250 | ||||
ENC000471 | 0.377 | D0A3HB | 0.250 | ||||
ENC003087 | 0.367 | D05VIX | 0.236 | ||||
ENC000679 | 0.345 | D0J6WW | 0.235 | ||||
ENC000368 | 0.333 | D0BZ7W | 0.230 | ||||
ENC001308 | 0.328 | D0X0RI | 0.226 | ||||
ENC000180 | 0.327 | D06IXT | 0.225 | ||||
ENC003090 | 0.323 | D08QMX | 0.225 |